RPRX · Royalty Pharma plc · Documents
$63.86
+0.11 (+0.17%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$36.72B
Shares
575.00M
Volume · Oct 23
4.02M
Avg daily vol (3M)
3M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-23 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-23 | 2026-09-30 | |
| Investor Event Transcript | — | 2026-09-14 | 2026-09-30 | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-08-05 | — | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| 8-K | — | 2026-06-04 | — | |
| 8-K | — | 2026-05-28 | 2026-05-22 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-13 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| 8-K | — | 2026-04-13 | — | |
| DEF 14A | — | 2026-04-10 | 2026-06-04 | |
| DEFA14A | — | 2026-04-10 | — | |
| ARS | — | 2026-04-10 | 2025-12-31 | |
| Investor Event Transcript | — | 2026-03-03 | 2026-03-31 | |
| 8-K | — | 2026-02-11 | — | |
| 10-K | — | 2026-02-11 | 2025-12-31 | |
| 8-K | — | 2025-12-22 | 2025-12-20 | |
| 8-K | — | 2025-12-22 | 2025-12-19 | |
| Investor Event Transcript | — | 2025-12-03 | 2025-12-31 | |
| 8-K | — | 2025-11-05 | — | |
| 10-Q | — | 2025-11-05 | 2025-09-30 | |
| 8-K | — | 2025-09-16 | — | |
| 8-K | — | 2025-08-13 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-08-06 | — | |
| 8-K | — | 2025-07-17 | — | |
| 8-K | — | 2025-05-19 | 2025-05-16 | |
| 8-K | — | 2025-05-12 | — | |
| 8-K | — | 2025-05-08 | — | |
| 10-Q | — | 2025-05-08 | 2025-03-31 | |
| DEFM14A | — | 2025-04-11 | — | |
| DEFA14A | — | 2025-04-11 | — | |
| ARS | — | 2025-04-11 | 2024-12-31 | |
| 8-K | — | 2025-04-11 | — | |
| DEFA14A | — | 2025-04-10 | — | |
| 8-K | — | 2025-04-10 | 2025-04-07 | |
| DEFA14A | — | 2025-03-05 | — | |
| PREM14A | — | 2025-02-13 | 2025-02-12 | |
| 10-K | — | 2025-02-12 | 2024-12-31 | |
| 8-K | — | 2025-02-11 | — | |
| DEFA14A | — | 2025-01-17 | — | |
| DEFA14A | — | 2025-01-16 | — | |
| DEFA14A | — | 2025-01-13 | — | |
| 8-K | — | 2025-01-13 | — | |
| DEFA14A | — | 2025-01-10 | — | |
| 8-K | — | 2025-01-10 | — | |
| 8-K | — | 2025-01-10 | — |
Showing 1–50 of 143 filings
Key facts
CIK
1802768
CUSIP
G7709Q104
13F (30d)
142 filings
130 filers
Visit website
Investor relations